We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Diaceutics Plc (DXRX) Ord GBP0.002

Sell:123.00p Buy:125.00p 0 Change: 3.00p (2.36%)
Market closed Prices as at close on 16 August 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:123.00p
Buy:125.00p
Change: 3.00p (2.36%)
Market closed Prices as at close on 16 August 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:123.00p
Buy:125.00p
Change: 3.00p (2.36%)
Market closed Prices as at close on 16 August 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Diaceutics PLC is a United Kingdom-based technology and solutions provider to pharma and biotech companies. It is engaged in research and development activities in the area of drug development science, precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions and Scientific & Advisory Services. Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.

Contact details

Address:
First Floor
Dataworks - Kingshall Building
BELFAST
BT6 9GW
United Kingdom
Telephone:
+ (0)
Website:
https://www.diaceutics.com/

Important dates

Future events
There are no future events available.
Past events
AGM 24 June 2024 24/06/24
Annual report 29 May 2024 29/05/24
Final results 21 May 2024 21/05/24
Trading Announcement 30 January 2024 30/01/24
Interim results 26 September 2023 26/09/23

General stock information

EPIC:
DXRX
ISIN:
GB00BJQTGV64
Market cap:
£104.73 million
Shares in issue:
84.46 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Ryan Keeling
    Chief Executive Officer, Executive Director
  • Nick Roberts
    Chief Financial Officer
  • Julie Browne
    Chief Operating Officer
  • Norma Thompson
    Vice President - Human Resources
  • Gosia Leitch
    Vice President - Engagement Solutions
  • Scott Phillips
    Vice President - Real-World Data
  • Peter Keeling
    Executive Director
  • Jillian Beggs
    Chief Commercial Officer
  • S Craig
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.